MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Create the #1 medical social network (Video/Pictures)
Global aggregator of choice for advanced medical technology business intelligence
Innovation & Royalty Aggregator
Royalty Pharma plc (NASDAQ:RPRX)
Finance & Acquisitions: Royalty Pharma
Zealand Pharma A/S (NASDAQ: ZEAL)
Organization & Developments: Zealand Pharma
Parents
Zealand Pharma A/S (NASDAQ: ZEAL)
Children
2018: Zealand Pharma: Partnerships And Looming Catalysts Make This A Buy - Zealand Pharma (Pending:ZEAL)
2022: Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit
2024: Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook_ seekingalpha.com
2024: Zealand Pharma: Survodutide Has Potential Beyond Obesity Treatment
2024: Zealand, Boehringer win FDA breakthrough status to treat fatty liver
2024: Zealand's hypoglycemia drug suffers another FDA rejection tied to CDMO inspection
2025: Zealand: Promising Roche-Partnered Obesity Drug Developer - But Stock Is Pricey
Jumps
Finance & Acquisitions: Zealand Pharma
Key People: Zealand Pharma